News By Tag
News By Location
FDA Says Yaz Users are 74% More at Risk for Blood Clotting
A recently concluded study done by the FDA has shown that, because of the hormone that is most active in the Yaz contraceptive medication, the drug puts users at an increased risk of developing a blood clot by about 74%.
Respected medical journals all around the world are reporting on drospirenone containing medications like Yaz upon the conclusion of studies done on them—all of these studies are finding a disturbingly strong link between Yaz and blooding clotting: “One 10-year study tracked blood clot rates in 15- to 49-year-old Danish women with no history of cardiovascular disease. The study found that women taking pills containing…drospirenone were at higher risk for blood clots than women taking pills containing levonorgestrel, one of the oldest synthetic progestins. A second study of more than 3,200 Dutch women found that compared with women who did not use birth control, women taking…drospirenone had a 6.3 times greater risk (for developing a blood clot.” Obviously, this information is upsetting because of the high levels of reported risk, which can lead to not only blood clotting, but DVT (Deep Vein Thrombosis), pulmonary embolism, and heart attack as well.
The law offices of Bond & Taylor deeply sympathize with all people who have taken Yaz and been afterwards injured. As a response to this widespread drug disaster, Bond & Taylor is giving out free legal counsel and advice to all women who have used the Yaz birth control medication. These individuals are advised to visit Bond & Taylor’s website at http://www.bondtaylorlaw.com/
Bond & Taylor, LLC
Candice McGurk, Managing Attorney
1 (800) 471-0314